Genital Crohn's disease in pediatrics and genetic associations

Erica Chang1, Caroline Chinchilla Putzeys2, Edward Hoffenberg3

  • 1Division of Pediatric Gastroenterology, Department of Pediatrics Children's Hospital of Philadelphia Philadelphia Pennsylvania USA.

JPGN Reports
|August 15, 2025
PubMed

Insights

Metastatic Crohn's disease (MCD) can manifest as genital edema, posing a diagnostic challenge. This rare condition requires further research for optimal patient management and understanding its underlying causes.

Area of Science:

  • Gastroenterology
  • Dermatology
  • Genetics

Background:

  • Metastatic Crohn's disease (MCD) is a rare extraintestinal manifestation of Crohn's disease (CD).
  • Genital edema, specifically penoscrotal swelling, is an uncommon presentation of MCD.
  • MCD can present before, during, or after the onset of gastrointestinal symptoms, complicating diagnosis.

Purpose of the Study:

  • To characterize the clinical features, disease course, and outcomes of patients with MCD presenting with genital edema.
  • To investigate the potential pathogenetic mechanisms, including genetic factors, involved in MCD.
  • To inform timely diagnosis and management strategies for this rare condition.

Main Methods:

  • Retrospective review of four patients diagnosed with metastatic Crohn's disease (MCD) manifesting as genital edema.
  • Analysis of clinical presentations, including painful and painless penoscrotal swelling with or without erythema.
  • Histopathological examination of scrotal tissue and genetic testing for pathogenic variants.

Main Results:

  • Patients presented with varying degrees of penoscrotal swelling and erythema.
  • Scrotal histopathology confirmed granulomatous inflammation.
  • Genetic testing revealed pathogenic variants in NOD2, COL7A1, and Chek2, alongside variants of uncertain significance.

Conclusions:

  • Genital edema is a rare but significant presentation of metastatic Crohn's disease.
  • Granulomatous inflammation and specific genetic variants may play a role in MCD pathogenesis.
  • Treatment responses to antibiotics, steroids, biologics, and methotrexate were mixed, highlighting the need for further research and clinical trials.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
383
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
324
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
541
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
232
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
271
Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
103.0K